Real world data from an experimental vaccine for birch pollen allergy, AllerT, have shown statistically significant reductions in seasonal allergy symptoms, as well as an effect into a second pollen season, according to the developer, Anergis SA. ---Subscribe to MedNous to access this article--- Company News Clinical Research